Oncology News

This past April, just after the Centers for Medicare & Medicaid Services released the highly-anticipated 2012 Medicare provider charge data, the New York Times published an article," Sliver of Medicare Doctors Get Big Share of Payout ."

AstraZeneca today announced that it has entered into a clinical study collaboration with Kyowa Hakko Kirin for a Phase I/Ib immuno-oncology study that will evaluate the safety and efficacy of two separate combinations of three investigational compounds in multiple solid tumours.

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

Top 7 Myths About HIPAA Security Risk Analysis : The Department of Health and Human Services Office for Civil Rights' pilot program to conduct HIPAA privacy and security audits showed that the top deficiency among audited organizations was the lack of a sufficient risk analysis plan.

Top 7 Myths About HIPAA Security Risk Analysis : The Department of Health and Human Services Office for Civil Rights' pilot program to conduct HIPAA privacy and security audits showed that the top deficiency among audited organizations was the lack of a sufficient risk analysis plan.

The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer , report researchers from the University of Pittsburgh Cancer Institute , partner with UPMC CancerCenter.

Maia Matteson and Kelly Geerdes, vacationing from Colorado, slap on the Hawaiian Tropic suntan lotion Tuesday overlooking Cowell Beach.

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 .

Research Triangle Park's CivaTech Oncology raised $1.5 million in a new round and doubled the target for this latest round to $2 million.

Years ago, journalists who had breast cancer fought with words to inform other women with breast cancer that, in many cases, they didn't need a mastectomy.

Becker's Hospital Review has named Loyola University Medical Center to its 2014 edition of "100 Hospitals and Health Systems with Great Oncology Programs," a compilation of organizations that are leading the way in quality patient care, cancer outcomes and research.

Pfizer Inc , which in May officially abandoned its bid to buy British rival AstraZeneca Plc, reported higher-than-expected second-quarter revenue, helped by growing demand for its cancer medicines.

Pfizer Inc, which in May officially abandoned its bid to buy British rival AstraZeneca Plc, reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

A Sheffield cancer expert has given a cautious welcome to a new breast cancer treatment which promises to replace long radiotherapy sessions with a single, targeted shot.

WCA Hospital officials announ-ced the hospital has been awarded a three-year term of reaccreditation in Posi-tron Emission Tomography as the result of an extensive review by the American College of Radiology.

A photograph that looks totally fine could reveal a potentially deadly cancer. It's a tiny white spot in the eye, that most people wouldn't even notice.

Today, 12 years ago, my life's priorities changed dramatically when my wife's doctor uttered three words, "you have cancer."

You should read the following discussion and analysis together with our consolidated financial statements and the related notes included elsewhere in this Annual Report on Form 10-K.

After removing a tumor, surgeons are confronted with an unfortunate reality: they can't be sure they got it all.

Well ahead of schedule, the US Food and Drug Administration today expanded the approved use of Imbruvica to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17 , associated with poor responses to standard treatment for CLL.